IP Verse

Curevac Ag opposition analysis

COMPANY ANALYSIS

Latest patents of Curevac Ag opposed by its competitors

Patent:
EP4023755
Grant Date:
Apr 26, 2023
Title:
Artificial Nucleic Acid Molecules For Improved Protein Expression
Oppositions:
4
Patent:
EP3521456
Grant Date:
Jan 4, 2023
Title:
Methods And Means For Enhancing Rna Production
Oppositions:
3
Patent:
EP3708668
Grant Date:
Jul 27, 2022
Title:
Artificial Nucleic Acid Molecules For Improved Protein Expression
Oppositions:
4
Patent:
EP3283125
Grant Date:
Dec 29, 2021
Title:
Lyophilization Of Rna
Oppositions:
2
Patent:
EP3115064
Grant Date:
Nov 24, 2021
Title:
Rna-Coded Antibody
Oppositions:
1
Patent:
EP2680880
Grant Date:
Nov 10, 2021
Title:
Vaccination In Newborns And Infants
Oppositions:
1
Patent:
EP3297682
Grant Date:
Jul 14, 2021
Title:
Dry Powder Composition Comprising Long-Chain Rna
Oppositions:
2
Patent:
EP3298142
Grant Date:
Jul 14, 2021
Title:
Dry Powder Composition Comprising Long-Chain Rna
Oppositions:
2
Patent:
EP3294326
Grant Date:
Apr 21, 2021
Title:
Prime-Boost Regimens Involving Administration Of At Least One Mrna Construct
Oppositions:
1
Patent:
EP3334828
Grant Date:
Oct 28, 2020
Title:
Method Of Increasing The Replication Of A Circular Dna Molecule
Oppositions:
2

Competitors of Curevac Ag

BIONTECH SE

STRAWMAN LIMITED

SANOFI

Want to track Curevac Ag?

Feel free to send us a message here and we will get back to you